Akebia defends patent for prolyl hydroxylase inhibitors before European Patent Office

Client(s) Akebia Therapeutics, Inc.

Jones Day advises Akebia Therapeutics, Inc. on defending a patent covering prolyl hydroxylase inhibitors before the European Patent Office.